GALLIAPHARM DIN 02503603
Status: Marketed
Holder: ECKERT & ZIEGLER RADIOPHARMA GMBH
Health Canada record
| Active ingredient(s) | GALLIUM 68 Ga CHLORIDE 1.85 GBQ |
|---|
| Dosage form | Solution |
|---|
| Route | 0-Unassigned |
|---|
| Schedule | SCHEDULE C |
|---|
| Class | Radiopharmaceutical |
|---|
| ATC | V09X OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
|---|
| Original market date | 10-Jul-2023 |
|---|
| Current status date | 10-Jul-2023 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Eckert & Ziegler Radiopharma GmbH — licence , not currently licensed, last inspection rating C (2024-09-27).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GALLIUM 68 Ga CHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02492806 | GALLI EO | IRE ELIT S.A. | Solution | GALLIUM 68 Ga CHLORIDE 1.85 GBQ | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 24092 | 2020-08-19 | New Drug Submission (NDS) | |
Request a quote for GALLIAPHARM
How to read a Canadian DIN record